Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Critical Mineral Executive Order Issued by President Donald Trump (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vigil Neuroscience Inc VIGL

Healthcare Biotechnology
Vigil Neuroscience, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based... see more

Current News (NDAQ:VIGL)

Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

GlobeNewswire 12 days ago

Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum

GlobeNewswire March 11, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

PR Newswire February 20, 2025

Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire January 30, 2025

Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer's Disease

GlobeNewswire January 23, 2025

Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones

GlobeNewswire January 8, 2025

Vigil Neuroscience to Present at Upcoming Investor Conferences

GlobeNewswire November 12, 2024

Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire November 7, 2024

Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference

GlobeNewswire November 5, 2024
View More News ››

Opinion & Analysis (NDAQ:VIGL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VIGL)

Vigil Neuroscience to Present at Guggenheim Securities SMID

News; $VIGL Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech ConferenceWATERTOWN, Mass., Jan. 30, 2025 (GLOBE...
whytestocks - January 30, 2025

Vigil Neuroscience (NASDAQ:VIGL): A Precision Approach to Ne

Looks like a promising play in the neuro space. VIGL's TREM2 agonist approach for rare neurodeg diseases is intriguing. Phase 2...
MikeTester - January 23, 2025

Buy buddy buy because it's taking off this morning.

So good luck to all of you shareholders.
coolfooldumbguy - January 23, 2025

Vigil Neuroscience, Inc. (VIGL): A Promising Biotech Poised

http://beyondspx.com/2024/08/03/vigil-neuroscience-inc-vigl-a-promising-biotech-poised-to-revolutionize-neurodegenerative-disease...
MikeTester - August 3, 2024

Vigil Neuroscience Provides Update on Clinical Development S

Breaking News: $VIGL Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval...
whytestocks - July 18, 2024

Going to $5+ easily

Next week. 
Garanga - July 5, 2024
View more Bullboard ››

Fiddlehead Resources Corp.

Fiddlehead Resources Corp.

Fiddlehead Resources Corp. is a TSXV listed Cardium-focused oil and gas producer with 1,750 boepd of low decline, high ...
View More »